Toronto Dominion Bank Raises Holdings in Agilent Technologies Inc (A)

Share on StockTwits

Toronto Dominion Bank raised its stake in Agilent Technologies Inc (NYSE:A) by 15.2% in the first quarter, HoldingsChannel.com reports. The firm owned 228,587 shares of the medical research company’s stock after acquiring an additional 30,240 shares during the period. Toronto Dominion Bank’s holdings in Agilent Technologies were worth $18,369,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently modified their holdings of A. Vanguard Group Inc raised its stake in shares of Agilent Technologies by 0.8% in the 3rd quarter. Vanguard Group Inc now owns 24,155,483 shares of the medical research company’s stock valued at $1,703,929,000 after buying an additional 194,607 shares in the last quarter. Geode Capital Management LLC raised its stake in shares of Agilent Technologies by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 4,234,035 shares of the medical research company’s stock valued at $285,139,000 after buying an additional 285,330 shares in the last quarter. Northern Trust Corp raised its stake in shares of Agilent Technologies by 2.0% in the 4th quarter. Northern Trust Corp now owns 3,807,998 shares of the medical research company’s stock valued at $256,888,000 after buying an additional 75,416 shares in the last quarter. Findlay Park Partners LLP acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $246,229,000. Finally, Cantillon Capital Management LLC raised its stake in shares of Agilent Technologies by 0.7% in the 4th quarter. Cantillon Capital Management LLC now owns 3,557,589 shares of the medical research company’s stock valued at $239,994,000 after buying an additional 24,411 shares in the last quarter.

A has been the subject of a number of recent analyst reports. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Thursday. Barclays dropped their target price on shares of Agilent Technologies from $88.00 to $86.00 and set an “overweight” rating for the company in a research report on Wednesday. Bank of America reiterated a “buy” rating and set a $87.00 target price (up previously from $78.00) on shares of Agilent Technologies in a research report on Thursday, February 21st. UBS Group initiated coverage on shares of Agilent Technologies in a research report on Friday, March 15th. They set a “buy” rating and a $92.00 target price for the company. Finally, Cowen increased their target price on shares of Agilent Technologies from $80.00 to $90.00 and gave the stock an “outperform” rating in a research report on Tuesday, March 26th. Three research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Agilent Technologies currently has a consensus rating of “Buy” and a consensus target price of $86.58.

Shares of Agilent Technologies stock traded up $0.50 during mid-day trading on Friday, reaching $69.80. 77,049 shares of the stock were exchanged, compared to its average volume of 2,627,951. Agilent Technologies Inc has a fifty-two week low of $60.42 and a fifty-two week high of $82.27. The company has a quick ratio of 2.79, a current ratio of 3.41 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $21.48 billion, a P/E ratio of 24.92, a price-to-earnings-growth ratio of 1.88 and a beta of 1.33.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Tuesday, May 14th. The medical research company reported $0.71 EPS for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the company earned $0.65 EPS. The firm’s revenue was up 2.7% compared to the same quarter last year. On average, equities analysts anticipate that Agilent Technologies Inc will post 3.06 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 24th. Shareholders of record on Tuesday, April 2nd were issued a dividend of $0.164 per share. This represents a $0.66 dividend on an annualized basis and a yield of 0.94%. The ex-dividend date was Monday, April 1st. Agilent Technologies’s dividend payout ratio is currently 23.66%.

In other Agilent Technologies news, Director Paul N. Clark sold 2,823 shares of the stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $80.31, for a total transaction of $226,715.13. Following the sale, the director now owns 88,857 shares of the company’s stock, valued at approximately $7,136,105.67. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Michael Tang sold 6,728 shares of the stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $80.50, for a total transaction of $541,604.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,583 shares of company stock worth $3,855,924.

COPYRIGHT VIOLATION NOTICE: “Toronto Dominion Bank Raises Holdings in Agilent Technologies Inc (A)” was originally reported by Week Herald and is the sole property of of Week Herald. If you are reading this report on another site, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this report can be viewed at https://weekherald.com/2019/05/17/toronto-dominion-bank-raises-holdings-in-agilent-technologies-inc-a.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: Asset Allocation and Your Retirement

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.